Diseases, Conditions, Syndromes

SARS-CoV-2 protein caught severing critical immunity pathway

Over the past two years, scientists have studied the SARS-CoV-2 virus in great detail, laying the foundation for developing COVID-19 vaccines and antiviral treatments. Now, for the first time, scientists at the Department ...

Medical research

Researchers identify potential new antiviral drug for COVID-19

The experimental drug TEMPOL may be a promising oral antiviral treatment for COVID-19, suggests a study of cell cultures by researchers at the National Institutes of Health. TEMPOL can limit SARS-CoV-2 infection by impairing ...

Genetics

Human lung proteins can advance or thwart SARS-CoV-2 infections

Researchers have taken an important step toward understanding the microscopic battle that plays out between our lung cells and the SARS-CoV-2 virus that causes COVID-19. A UC Berkeley-led study has identified specific proteins ...

Medications

New drug candidate against COVID-19

SARS-CoV-2, the virus responsible for the COVID-19 pandemic, arrived one year ago and turned our lives upside-down.

Diseases, Conditions, Syndromes

What we do and do not know about COVID-19's infectivity and viral load

As the COVID-19 pandemic spreads, it has become clear that people need to understand basic facts about SARS-CoV-2, the virus that causes COVID-19, to make informed health care and public policy decisions. Two basic virological ...

Diseases, Conditions, Syndromes

VirScan offers new insights into COVID-19 antibody response

A tool designed to detect viral history in a drop of blood has gotten an upgrade in the age of COVID-19. VirScan, a technology that can determine which of more than 1,000 different viruses have infected a person, can now ...

page 28 from 40